Larvol Delta - ViralClear-to-host-conference-call-on-June-9th-to-discuss-upcoming-and-recent-developments-for-phase-II-human-clinical-trials-of-its-broadspectrum-oral-antiviral-candidate-for-treatment-of-Covid19

remdesivir - Generic mfg.

Vicromax (merimepodib) - BioSig Tech

https://www.globenewswire.com/news-release/2020/06/01/2041615/0/en/ViralClear-to-Host-Conference-Call-on-June-9th-to-Discuss-Upcoming-and-Recent-Developments-for-Phase-II-Human-Clinical-Trials-of-its-Broad-Spectrum-Oral-Anti-viral-Candidate-for-Tr.html

Jun 1, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next